The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Cellectis; ImmunoGen; Incyte; Janssen; Jazz Pharmaceuticals; Menarini; Novartis; Otsuka; Pfizer; SERVIER; Shire
Research Funding - Amgen; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; SERVIER
Prognostic factors of overall (OS) and relapse-free survival (RFS) for patients with acute myeloid leukemia (AML) in remission after intensive chemotherapy (IC): Multivariate analyses from the QUAZAR AML-001 trial of oral azacitidine (Oral-AZA).
 
Gail J. Roboz
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; Amphivena; argenx; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Celltrion; Daiichi Sankyo; Eisai; Genentech/Roche; Genoptix; GlaxoSmithKline; Helsinn Therapeutics; Janssen; Jazz Pharmaceuticals; MedImmune; MEI Pharma; Mesoblast; Novartis; Orsenix; Otsuka; Pfizer; Roche; Sandoz; Takeda; Trovagene
Research Funding - Abbvie (Inst); Agios (Inst); amphivena (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); Cellectis (Inst); CTI (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Agios; Amgen; Amphivena; Array BioPharma; Astex Pharmaceuticals; Bayer; Celgene; Celltrion; Clovis Oncology; Eisai; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche/Genentech; Sandoz; Sunesis Pharmaceuticals
 
Andrew H. Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Farhad Ravandi
Honoraria - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Jazz Pharmaceuticals; Novartis; Orsenix; Pfizer; Takeda
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Celgene; Certara Inc; Jazz Pharmaceuticals; Orsenix; Syros Pharmaceuticals; Taiho Oncology; Taiho Oncology
Research Funding - Amgen; Bristol-Myers Squibb; Cellerant; Macrogenics; Selvita; Xencor
 
Christopher Pocock
No Relationships to Disclose
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Hervé Dombret
No Relationships to Disclose
 
Kimmo Porkka
Honoraria - Celgene; Novartis
Research Funding - Celgene; Novartis
 
Ignazia La Torre
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol Meyer Squibb
 
Barry Skikne
No Relationships to Disclose
 
Barry Skikne
Consulting or Advisory Role - Bristol-Myers Squibb
 
Keshava Kumar
No Relationships to Disclose
 
Jianhua Zhong
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
C. L. Beach
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Hartmut Dohner
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Helsinn Therapeutics; Janssen Oncology; Jazz Pharmaceuticals; Novartis; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)